Incyte
INCY
#1220
Rank
NZ$31.54 B
Marketcap
NZ$158.52
Share price
-2.10%
Change (1 day)
48.90%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2024: NZ$0.54 Billion

According to Incyte's latest financial reports the company's current earnings are NZ$4.81 Billion. In 2024 the company made an earning of NZ$0.54 Billion a decrease over its 2023 earnings that were of NZ$1.43 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2024

Annual earnings

Year Earnings Change
2024NZ$0.54 B-62.04%
2023NZ$1.43 B57.66%
2022NZ$0.90 B-7.24%
2021NZ$0.98 B-345.65%
2020-NZ$0.4 Billion-147.7%
2019NZ$0.83 B322.02%
2018NZ$0.19 B-136.94%
2017-NZ$0.54 Billion-390.76%
2016NZ$0.18 B1322%
2015NZ$12.98 M-115.56%
2014-NZ$83.44 Million-41.4%
2013-NZ$0.15 Billion87.67%
2012-NZ$75.87 Million-74.9%
2011-NZ$0.31 Billion843.59%
2010-NZ$32.03 Million-88.68%
2009-NZ$0.29 Billion1.37%
2008-NZ$0.28 Billion86.16%
2007-NZ$0.15 Billion17.64%
2006-NZ$0.13 Billion-28.62%
2005-NZ$0.18 Billion-36.1%
2004-NZ$0.28 Billion-2.03%
2003-NZ$0.29 Billion22.26%
2002-NZ$0.24 Billion-27.39%
2001-NZ$0.33 Billion198.72%
2000-NZ$0.11 Billion132.2%
1999-NZ$46.33 Million-556.86%
1998NZ$10.13 M-37.23%
1997NZ$16.15 M-259.32%
1996-NZ$10.14 Million-45.87%
1995-NZ$18.74 Million-9.17%
1994-NZ$20.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$28.10 B 929.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$20.36 B 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.67 B 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.16 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-NZ$78.93 Million-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$0.12 Billion-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-NZ$49.91 Million-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$95.47 Million-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA